NRX Pharmaceuticals Capital Expenditures (CapEx) Growth & History (NRXP)

NRX Pharmaceuticals's capital expenditures (capex) was $0 for fiscal 2024.

View full NRX Pharmaceuticals company overview

NRX Pharmaceuticals annual capital expenditures (capex) history

NRX Pharmaceuticals annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31$0−$3,000
20232023-12-31$3,000−$7,000−70.00%
20222022-12-31$10,000$3,000+42.86%
20212021-12-31$7,000$5,000+250.00%
20202020-12-31$2,000

NRX Pharmaceuticals capital expenditures (capex) trends

Between the periods ended 2020-12-31 and 2024-12-31, NRX Pharmaceuticals's capital expenditures (capex) decreased from $2,000 to $0, a change of −$2,000. The latest reported quarter, Q1 2025, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review NRX Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about NRXP yet. Start the conversation.

Write the first post